GB2066047A - The production of medicaments and materials to render microorganisms harmless in human bodies and foodstuffs - Google Patents
The production of medicaments and materials to render microorganisms harmless in human bodies and foodstuffs Download PDFInfo
- Publication number
- GB2066047A GB2066047A GB8041229A GB8041229A GB2066047A GB 2066047 A GB2066047 A GB 2066047A GB 8041229 A GB8041229 A GB 8041229A GB 8041229 A GB8041229 A GB 8041229A GB 2066047 A GB2066047 A GB 2066047A
- Authority
- GB
- United Kingdom
- Prior art keywords
- substrate
- process according
- irradiated
- magnetic field
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 13
- 239000003814 drug Substances 0.000 title claims abstract description 11
- 239000000463 material Substances 0.000 title claims abstract description 8
- 239000000758 substrate Substances 0.000 claims abstract description 28
- 239000000243 solution Substances 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 16
- 239000007788 liquid Substances 0.000 claims abstract description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 6
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 6
- 239000011780 sodium chloride Substances 0.000 claims abstract description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910052802 copper Inorganic materials 0.000 claims abstract description 5
- 239000010949 copper Substances 0.000 claims abstract description 5
- 239000007787 solid Substances 0.000 claims abstract description 5
- 230000003068 static effect Effects 0.000 claims abstract description 5
- 229910052742 iron Inorganic materials 0.000 claims abstract description 3
- 238000009877 rendering Methods 0.000 claims abstract 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract 2
- 229910052737 gold Inorganic materials 0.000 claims abstract 2
- 239000010931 gold Substances 0.000 claims abstract 2
- 229910001092 metal group alloy Inorganic materials 0.000 claims abstract 2
- 229910052709 silver Inorganic materials 0.000 claims abstract 2
- 239000004332 silver Substances 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims description 11
- 230000005670 electromagnetic radiation Effects 0.000 claims description 9
- 239000011521 glass Substances 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 230000005672 electromagnetic field Effects 0.000 claims 1
- 230000004907 flux Effects 0.000 claims 1
- 230000001702 transmitter Effects 0.000 claims 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 230000001678 irradiating effect Effects 0.000 abstract 1
- 201000005485 Toxoplasmosis Diseases 0.000 description 4
- 239000003708 ampul Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/12—Microwaves
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Magnetic Treatment Devices (AREA)
- Medicinal Preparation (AREA)
Abstract
A process for the production of (a) medicaments for rendering microorganisms harmless in human bodies and (b) materials for disinfecting foodstuffs comprises irradiating a substrate with electromagnetic waves, preferably microwaves in a static magnetic field which is produced between two opposite magnetic poles. The substrate is a solid body, e.g. made of copper, iron or a metal alloy; a liquid, e.g. an isotonic common salt solution, Ringer's solution or a colloidal solution, in particular such a solution of copper, silver or gold, or the substrate may be a gas. A secondary product is obtained using the irradiated substrate by bringing the substrate as close as possible to the irradiated substrate in the magnetic field.
Description
SPECIFICATION
The production of medicaments and means to ren
der microorganisms harmless
This invention relates to a process for the production of medicaments and of means to render mic
roorganisms harmless in a physical manner, and is substantially characterised in that a substrate is
ir;adiated with electromagnetic waves in a static magnetic field which is produced between two opposite magnetic poles.
I have found that it is possible to destroy harmful or undesired microorganisms such as bacteria, protozoa, fungi and viruses in biological and nonbiological systems, or it is at least possible to deactivate them until they are no longer harmful, by allowing a substrate (carrier substance) irradiated according to the invention to act thereupon.
The starting point of th is invention was the following observation: long-term toxoplasmosis patients having a positive
Sabin-Feldmann test were given two to three injections of an isotonic common salt solution in an interval of from three to four days, the solution, as described in the following, having been irradiated with electromagnetic waves (of lowfrequency) in a static magnetic field.
The Sabin-Feldmann test was repeated approximately two weeks after the first injection and was then negative and the subjective and objective disease symptoms permanently failed to reappear.
The medicament which was effective against toxoplasmosis was produced in the following manner:
Two permanent bar magnets of the 10846700 OXIT 300 K-369720 type, produced by Thyssen Edelstahlwerke AG, were arranged so that the north pole of one magnet and the south pole of the other magnet were positioned opposite each other with a working space of 24 cm, such that both bar magnets had a common longitudinal axis.
The magnets were each held by a magnet carrier pivotable about 360" made of unmagnetisable material, whereby the foot, designed as a sliding block, of such a magnet carrier was moveable relative towards the other foot in the guide rail of a displacement device by means of a threaded spindle.
A holding device made of unmagetisable material was located in the centre between the two magnetic poles.
A glass ampoule containing a sterile isotonic common salt solution was inserted into the holding device, level with the magnetic poles. The ampoule was irradiated using a transmitter designed as a signal generator, such that the transmitter, whose output was 1.5 W, was moved as close as possible to the ampoule and was operated for from 15 to 20 seconds vertically to the magnetic field.
For the treatment of toxoplasmosis, the frequencies of 14584 S-i and 14596 s-1 have been found to be particularly effective during irradiation of the substrate which, apart from an isotonic common salt solution, may also be Ringer's solution or any other physiologically harmless solution.
The isotonic common salt solution irradiated thus
with electromagnetic radiation in the magnetic field
was then injected immediately after the irradiation
thereof.
However, relief or alleviation from the discomfort
caused by toxoplasmosis and other illness conditions was also achieved when the irradiated means was not used until days after the production thereof, for which use, however, there is a pre-requisite that the irradiated means must not be exposed to any
other stronger technical magnetic or electromagnetic interference fields.
The frequency of the electromagnetic irradiation for the production ofthe medicament or, generally, the means for combatting microorganisms depends on the type of microorganism and, in principle, is not restricted to the low frequency range, as specified in the example mentioned. It is up to the skilled man to determine the effective frequencies in each particu
lar case, and the same applies to the optimum coordination between the strength of the static magnetic field applied and the energy of the electromagnetic alternating field.
The effect of the magnetic field may be produced in various ways. The field may be produced by one or more permanent magnets or by one or more electromagnets.
The strength of the magnetic field may be adjusted to the required magnitude by changing the spacing of the magnetic poles and/or by changing the intensity of current.
The electromagnetic radiation may be irradiated vertically or parallel or obliquelyto the field lines of the magnetic field.
The frequency of the irradiated electromagnetic alternating field preferably lies within the low frequency range.
The energy of the electromagnetic radiation acting on the substrate may be adjusted by varying the transmitter power of the transmitter for the electromagnetic radiation and/or by varying the spacing of the transmitter from the substrate to be irradiated.
Solid bodies, liquids and gases may be used as the substrate. During irradiation, a liquid or gas substrate is contained in a vessel made of unmagnetisable material, preferably glass.
If a metal disc is used as a solid substrate, then such a disc made of copper or iron is particularly suitable.
If liquids are used as the substrate, then mineral solutions and colloidal solutions in particular are suitable.
The use of the medicaments produced according to the process of the invention is not restricted.
Liquid, irradiated substrates (carrier substances) may be injected. They may also be used for baths.
If irradiated metal discs (carrier substances) are used externally, then this is carried out by direct skin contact for a longer period of time, preferably at the acupuncture points.
Carrier substances produced according to the invention are also capable of transferring their effect onto substrates which are not irradiated with electromagnetic radiation in the magnetic field. As a result thereof, a secondary carrier substance (secondary product) is produced. This is effected by placing
a substrate which has not been previously irradiated
in the magnetic field as close as possible to the car
rier substance.
The carrier substances do not only act on microor
ganisms in human bodies, but also on microorgan
isms in other areas. Therefore, they may also be
used for disinfection purposes, such as in the foods
tuffs field.
Claims (17)
1. A process for the production of medicaments
and of means to render microorganisms harmless,
which comprises applying a magnetic and an electromagnetic field on a substrate (carrier substance) to be used as a medicament or a means to render
microorganisms harmless, the substrate being
irradiated with electromagnetic waves in a static
magnetic field between two opposite magnetic poles.
2. A process according to Claim 1, wherein the magnetic field is produced by one or more permanent magnets.
3. A process according to Claim 1, wherein the magnetic field is produced by one or more electromagnets.
4. A process according to Claim 2 or 3, wherein the strength of the magnetic field is adjusted to the required magnitude by changing the spacing of the magnetic poles and/or by changing the intensity of current.
5. A process according to any one of Claims 1 to 4, wherein the electromagnetic radiation is irradiated perpendicularly to the magnetic field.
6. A process according to any one of Claims 1 to 4, wherein the electromagnetic radiation is irradiated parallel or obliquely to the flux of the magnetic field.
7. A process according to Claim 5 or 6, wherein the frequency of the irradiated electromagnetic alternating field lies within the low frequency range.
8. A process according to any one of Claims 5 to 7, wherein the energy of the electromagnetic radiation acting on the substrate is adjusted by the trans mitter power of the transmitter for the electromagnetic radiation and/or by the spacing of the transmitter from the substrate to be irradiated.
9. A process according to any one of Claims 1 to 8, wherein a solid body, a liquid or a gas is used as the substrate, and during irradiation the liquid or the gas is contained in a vessel made of unmagnetisable material, preferably glass.
10. A process according to Claim 9, wherein the solid substrate is a metal disc, particularly made of copper, iron orof a metal alloy.
11. A process according to Claim 9, wherein the liquid substrate is a mineral solution, in particular isotonic common salt solution of Ringer's solution, or a colloidal solution, in particular of copper, silver or gold.
12. A process according to Claim 1, substantially as hereinbefore described.
13. A medicament consisting of or containing a substrate (carrier substance) irradiated according to any one of Claims 1 to 12.
14. A material for rendering microorganisms harmless, consisting of or containing a substrate (carrier substance) irradiated according to any one of
Claims 1 to 12.
15. A process for the production of a secondary product, which comprises bringing a substrate as close as possible to a carrier substance produced according to any one of Claims 1 to 12 in the magnetic field.
16. A medicament consisting of or containing a secondary product produced according to Claim 15.
17. A material for rendering microorganisms harmless, consisting of or containing a secondary product produced according to Claim 15.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792952592 DE2952592A1 (en) | 1979-12-28 | 1979-12-28 | MANUFACTURE OF MEDICINAL PRODUCTS AND MICRO-ORGANISM DETACHING AGENTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB2066047A true GB2066047A (en) | 1981-07-08 |
| GB2066047B GB2066047B (en) | 1984-04-04 |
Family
ID=6089784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8041229A Expired GB2066047B (en) | 1979-12-28 | 1980-12-23 | Production of medicaments and materials to render microorganisms harmless in human bodies and foodstuffs |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE2952592A1 (en) |
| FR (1) | FR2477418A1 (en) |
| GB (1) | GB2066047B (en) |
| IT (1) | IT1141649B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3343586A1 (en) * | 1983-11-29 | 1985-06-05 | Herbert Dr. 1000 Berlin Pilgrimm | Method for sterilizing a medium and device for conduct thereof |
| WO2007137833A1 (en) * | 2006-05-30 | 2007-12-06 | Gerald Jentsch | Specifically adapted plant-derived redox catalyst and method for the production thereof |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2164668T3 (en) * | 1992-10-30 | 2002-03-01 | Gennady Alexandrovich Markov | COMPOSITE FOR THE BIOLOGICAL STIMULATION AND CORRECTION OF THE PHENOTYPE OF AN ORGANISM AND A PROCEDURE FOR ITS PRODUCTION. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR963012A (en) * | 1950-06-28 | |||
| US3626934A (en) * | 1970-04-06 | 1971-12-14 | Ernest R Andis | Massaging device |
| GB1513605A (en) * | 1975-09-04 | 1978-06-07 | Mabuchi Motor Co | Beauty treatment device |
| US4079733A (en) * | 1976-06-02 | 1978-03-21 | Hamburg Group | Percussion vibrator device for treatment of patients to assist expectoration of retained secretions |
-
1979
- 1979-12-28 DE DE19792952592 patent/DE2952592A1/en not_active Ceased
-
1980
- 1980-12-23 GB GB8041229A patent/GB2066047B/en not_active Expired
- 1980-12-24 IT IT68995/80A patent/IT1141649B/en active
- 1980-12-29 FR FR8027708A patent/FR2477418A1/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3343586A1 (en) * | 1983-11-29 | 1985-06-05 | Herbert Dr. 1000 Berlin Pilgrimm | Method for sterilizing a medium and device for conduct thereof |
| WO2007137833A1 (en) * | 2006-05-30 | 2007-12-06 | Gerald Jentsch | Specifically adapted plant-derived redox catalyst and method for the production thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2477418A1 (en) | 1981-09-11 |
| IT1141649B (en) | 1986-10-01 |
| DE2952592A1 (en) | 1981-07-02 |
| IT8068995A0 (en) | 1980-12-24 |
| GB2066047B (en) | 1984-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Keller et al. | Microwave treatment for sterilization of phytoplankton culture media | |
| Brasch et al. | Ultrashort application time of penetrating electrons: A tool for sterilization and preservation of food in the raw state | |
| DE2249190C3 (en) | Mass sterilization method | |
| DE3875558D1 (en) | SOLUTION FOR USE AS RINSING LIQUID IN THE DESTRUCTION OF NON-BODY DEPOSITS IN HUMAN AND ANIMAL TISSUES OR BODIES. | |
| CA2196165A1 (en) | Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods | |
| ATE54052T1 (en) | MICROWAVE STERILISER. | |
| DE69120174D1 (en) | Sterilization using plasma and pulsed treatment with antimicrobial agents | |
| ES2061673T3 (en) | INACTIVATION OF VIRUSES AND BACTERIA. | |
| RU94022017A (en) | Method of treatment of acne or bread pseudofolliculitis, method of composition preparing, use of enzyme ornitine decarboxylase inhibitor for acne and bread folliculitis treatment | |
| Dobrynin et al. | Cold plasma sterilization of open wounds: live rat model | |
| Poh et al. | Osteogenic Effect and Cell Signaling Activation of Extremely Low‐Frequency Pulsed Electromagnetic Fields in Adipose‐Derived Mesenchymal Stromal Cells | |
| ATE242960T1 (en) | DEVICE AND METHOD FOR PHOTOACTIVATION | |
| DE3776367D1 (en) | STERILIZATION PROCEDURE. | |
| ATE134471T1 (en) | MICROWAVE TREATMENT | |
| GB2066047A (en) | The production of medicaments and materials to render microorganisms harmless in human bodies and foodstuffs | |
| IT1216466B (en) | METHOD FOR STERILIZING OBJECTS TO BE STERILIZED AND STERILIZATION DEVICE. | |
| KR920012112A (en) | Process for preparing pasteurized iron-free human transferrin and uses thereof | |
| RU2155081C1 (en) | Method and device for treating substance in magnetic field | |
| RU2000811C1 (en) | Method for sterilization and disinfection of medical equipment | |
| ATA308874A (en) | METHODS FOR THE HEAT TREATMENT, IN PARTICULAR STERILIZATION OR DISINFECTION, OF HYDROGEN SLUDGE AND DEVICE FOR CARRYING OUT THE PROCESS | |
| Alneami et al. | A comparison of six ultrasound stimulation types on pseudomonas aeruginosa growth in vitro | |
| RU2098134C1 (en) | Method of inactivation of enteric infection pathogen infectious activity and vaccine for animal immunization | |
| Chaplin | The effects of a one Tesla magnet on human fibroblast growth | |
| RU94013392A (en) | METHOD OF SKVORTSOV OF OBTAINING A BIOACTIVE RADIATION MEDICINE MEDICINE AND A DEVICE FOR IRRADIATING AN OBJECT BY BIOACTIVE ENERGY | |
| SU610797A1 (en) | Method of water sterilization |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19961223 |